logo
Mass Burn: SpaceX Deorbits Nearly 500 Starlink Satellites in 6 Months

Mass Burn: SpaceX Deorbits Nearly 500 Starlink Satellites in 6 Months

Yahoo2 days ago
PCMag editors select and review products independently. If you buy through affiliate links, we may earn commissions, which help support our testing.
Over a six-month stretch, hundreds of Starlink satellites met a fiery end in the Earth's atmosphere as SpaceX retired its aging hardware.
From December to May, SpaceX deorbited 472 Starlink satellites, according to a new filing with the Federal Communications Commission. The means the company deorbited about 2.6 satellites per day, a notable increase after having only deorbited 73 satellites in the previous six-month period.
SpaceX's satellites are designed to orbit the Earth for five years before they're retired and burn up in the Earth's atmosphere. In the FCC filing, SpaceX said 430 of the deorbited satellites belonged to the first-generation Starlink network. However, most of the satellites that reentered the atmosphere did so less than five years after beginning operations.
The remaining deorbited satellites belonged to the second-generation Starlink network. SpaceX didn't immediately respond to a request for comment, making it unclear why so many satellites were sent plunging back to the Earth. However, the Starlink network has grown to nearly 8,000 satellites, according to astronomer Jonathan McDowell, who tracks satellite launches.
In January, McDowell noticed the drastic spike in Starlink deorbits, and estimated the company was 'retiring and incinerating about 4 or 5 Starlinks every day." Since then, the number of Starlink satellites burning up the atmosphere has declined, he told PCMag, although his stats show another 200 satellites are facing disposal.
The large number of Starlink disposals raises questions about the potential impact. While Starlink satellites are designed to disintegrate as they burn up in the atmosphere, SpaceX in February revealed that small and mainly harmless debris fragments can continue flying toward Earth. In rare instances, they slip through, like the "2.5 kg piece of aluminum" from a Starlink satellite that fell near a farm in Canada.
Still, the company says the chance of its newest Starlink satellites causing human harm through falling debris is 'less than 1 in 100 million' due to improved designs and ongoing changes to make the hardware fully disintegrate during reentry. Nevertheless, astronomers and scientists have been concerned about the same Starlink satellites releasing chemicals in the atmosphere as they burn up, which might have unforeseen climate or ozone layer impacts.
In response, a group of astronomers last year called on the FCC to pause Starlink launches until the environmental effects of large satellite constellations can be fully investigated. So far, the new Republican-led FCC hasn't said if it'll embark on such a study. Meanwhile, SpaceX has previously said it designed the Starlink network to minimize any environmental impact.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Here's Why Aehr Test Systems Surged in June (Hint: It's AI related)
Here's Why Aehr Test Systems Surged in June (Hint: It's AI related)

Yahoo

time29 minutes ago

  • Yahoo

Here's Why Aehr Test Systems Surged in June (Hint: It's AI related)

Aehr Test Systems is not a one-trick pony, and the company is impressively diversifying its revenue streams. The market is speculating that its new customers could prove lucrative and lasting. 10 stocks we like better than Aehr Test Systems › Aehr Test Systems (NASDAQ: AEHR) stock rose by 35.5% in June, according to data provided by S&P Global Market Intelligence. The move comes as positive developments in the end markets that Aehr is targeting helped support the idea that the company can diversify its revenue streams and improve its growth in the process. The company is best known for its test and burn-in equipment for the silicon carbide (SiC) wafer-level burn-in (WLBI) market. As management notes, this end market contributed 90% of Aehr's revenue in 2024. Unfortunately, at least from a near-term perspective, the key driver for Aehr's SiC WLBI solutions is the electric vehicle (EV) market and its associated charging infrastructure. Aehr's key customers in this market, which include ON Semiconductor, have come under pressure due to the ongoing relatively high interest rate negatively impacting EV sales. For reference, and by way of example, Wall Street analysts expect ON Semiconductor's sales to decline by 16.5% in 2025. Consequently, Aehr needs to develop other markets to help offset weakness in its core SiC WLBI market. And the good news is it's not only doing that, but those markets are also in growth mode. The progress was noted in the third-quarter earnings presentation in April with CEO Gayn Erickson outlining that SiC WLBI revenue is now tracking to "less than 40%, with artificial intelligence (AI) processors burn-in representing over 35% of our business in just the first year." Furthermore, in the third quarter, Aehr had four customers accounting for 10% of its revenue, with three of them coming from new markets for Aehr: WLBI for AI processors Packaged part burn-in (PPBI) "for qualification and ongoing process monitoring of AI processors" "WLBI of gallium nitride (GaN) semiconductors" Fast forward to June, and the positive momentum in AI and GaN WLBI spending has continued with Nvidia's well-received earnings report coming at the end of May. Moreover, Nvidia is working on developing a data center architecture for the next generation of data centers, starting in 2027, and has named GaN semiconductor company Navitas Semiconductor as a partner. As such, the market is speculating that Navitas could be a potential customer of Aehr Test Systems. The growth of alternative revenue streams is a significant plus for Aehr's investment case, and demand for SiC WLBI is likely to improve over time as EV investment is expected to increase. All told, the company's revenue and earnings remain highly cyclical, but its new end markets are helping to reduce its heavy reliance on EV spending, which has benefited the stock in June. Before you buy stock in Aehr Test Systems, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Aehr Test Systems wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $699,558!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $976,677!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy. Here's Why Aehr Test Systems Surged in June (Hint: It's AI related) was originally published by The Motley Fool

Nvidia, Microsoft, Palantir Lead Wedbush's Top Tech Bets on $2T AI Boom
Nvidia, Microsoft, Palantir Lead Wedbush's Top Tech Bets on $2T AI Boom

Yahoo

time31 minutes ago

  • Yahoo

Nvidia, Microsoft, Palantir Lead Wedbush's Top Tech Bets on $2T AI Boom

July 4 - Wedbush Securities projects a more than 10% gain for major tech stocks in the second half of 2025, driven by a surge in enterprise and government AI spending. The top five picks are Nvidia (NASDAQ:NVDA), Meta Platforms (META), Microsoft (NASDAQ:MSFT), Palantir (NASDAQ:PLTR) and Tesla (NASDAQ:TSLA). Analysts estimate roughly $2 trillion will flow into AI initiatives over the next three years, unlocking new use cases and boosting demand for both software and semiconductors. Warning! GuruFocus has detected 4 Warning Signs with NVDA. Wedbush points to recent strength in tech amid tariff and geopolitical headwinds as a prelude to further market outperformance. They highlight the rollout of large language models and the true adoption of generative AI in corporate settings as key catalysts for renewed rallies. With enterprise consumption set to accelerate, we believe software and chip leaders are well positioned to lead this AI Revolution' through 2026, the note added. Investors will watch second?half earnings and AI deployment updates closely to see if these leaders can sustain the momentum. This article first appeared on GuruFocus. Sign in to access your portfolio

Ready-made stem cell therapies for pets could be coming
Ready-made stem cell therapies for pets could be coming

TechCrunch

time36 minutes ago

  • TechCrunch

Ready-made stem cell therapies for pets could be coming

Earlier this week, San Diego startup Gallant announced $18 million in funding to bring the first FDA-approved ready-to-use stem cell therapy to veterinary medicine. If it passes regulatory muster, it could create a whole new way to treat our fur babies. It's still an experimental field, even though people have been researching stem cells for humans for decades. Seven-year-old Gallant's first target is a painful mouth condition in cats called Feline Chronic Gingivostomatitis (FCGS), which Gallant says could receive FDA approval by early 2026. The field has shown some encouraging early results. Studies on dogs with arthritis showed improvements in pain and mobility, with some benefits lasting up to two years. But when researchers tried similar treatments for kidney disease in cats — that's another condition Gallant wants to tackle — the results were more mixed. What makes Gallant's approach different is convenience. Most stem cell treatments today require harvesting cells from the patient or donors with matching tissue, whereas Gallant's therapy uses ready-to-use cells from donor animals, even if they are a different species. Investors clearly see potential here. The funding round was led by existing backer Digitalis Ventures, with participation from NovaQuest Capital Management, which previously invested in the first FDA-approved human stem cell therapy. The company has an interesting backstory. Gallant's founder, Aaron Hirschhorn, previously sold DogVacay to its biggest rival in the dog-sitting marketplace, Rover. Hirschhorn passed away in 2021; Gallant is now led by Linda Black, who joined as its president and chief scientific officer from nearly the beginning. Gallant has now raised at least $44 million altogether from investors.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store